Express Pharma

BIRAC showcases biotech and medtech start-ups at Bharatiya Vyapar Mahotsav 2026

BIRAC’s pavilion features start-ups working on medical devices, rehabilitation systems and assistive technologies at Bharat Mandapam

0 3

The Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise of the Department of Biotechnology (DBT), Government of India, is showcasing its innovation and start-up ecosystem at a pavilion during the Bharatiya Vyapar Mahotsav (BVM) 2026, being held from August 12–15 at Bharat Mandapam, Pragati Maidan, New Delhi.

Organised jointly by the Confederation of All India Traders (CAIT) and India Trade Promotion Organisation (ITPO), BVM 2026 brings together traders, MSMEs, manufacturers, institutions, investors and policymakers under the theme “Made in India, Made for India, Made for the World”.

The BIRAC pavilion allows visitors, investors, industry leaders and the public to engage with biotech and medtech innovators and understand BIRAC’s schemes, funding instruments and infrastructure supporting the development of laboratory research into market-ready products.

Since its establishment, BIRAC has worked as an interface between India’s scientific research base and industry, supporting the conversion of research into enterprises and products. As an industry–academia interface agency under DBT, BIRAC has developed a network of incubators, bioclusters, accelerators and funding schemes supporting entrepreneurs from proof-of-concept to commercialisation.

BIRAC’s support includes seed and early-stage funding for validating ideas and developing prototypes, access to risk capital through venture funds and co-investment mechanisms, technology transfer and intellectual property (IP) support, bioincubation infrastructure, and regulatory and market-access support.

Its bioincubation network provides lab space, mentorship and technical support, including in tier 2 and tier 3 regions. BIRAC also runs social innovation programmes supporting technologies for affordable healthcare, assistive devices, and solutions for underserved and marginalised communities.

According to BIRAC, these programmes have supported start-ups and MSMEs across therapeutics, diagnostics, medical devices, agri-biotech, industrial biotechnology and clean energy.

A share of the start-ups featured at the BIRAC pavilion are working on medical technology and social impact, including prosthetics, robotic rehabilitation systems and assistive devices for persons with disabilities.

“BIRAC’s role has always gone beyond funding — to de-risk the innovation journey for India’s biotech entrepreneurs, connecting them to capital, infrastructure, mentorship and markets at every stage. The start-ups showcased at our pavilion this year, many of them working on assistive technologies and rehabilitation solutions, are a powerful example of how Indian innovation can be both cutting-edge and deeply inclusive. Platforms like the Bharatiya Vyapar Mahotsav allow us to bring these home-grown solutions closer to industry, investors and the public, and to reaffirm BIRAC’s commitment to building a self-reliant, globally competitive Indian bio-economy.” Stated Dr. Dhananjay Kumar Tiwary, Managing Director, BIRAC.

Reconstructive Healthcare Solutions  (RHS), founded in 2018 by a maxillofacial surgeon, is an ISO 13485-certified medtech company specialising in virtual surgical planning and 3D-printed anatomical models, surgical guides, splints, and dental and orthopaedic implants. Operating from a GMP facility at IMT Faridabad, Haryana, RHS combines imaging, software integration and manufacturing for patient-specific surgical care and healthcare education.

GenElek Technologies, an IIT Delhi-incubated medical robotics company, develops robotic exoskeletons for gait training and mobility rehabilitation. Its Sencibel Robotic Gait Trainer is a lower-limb robotic exoskeleton with multiple training modes, real-time monitoring and analytics for individuals with neurological and musculoskeletal impairments.

Exobot Dynamics Pvt. Ltd., incubated at IIT Delhi and backed by BIRAC, AIC, IHFC, SACC, NCPEDP, DST and FICCI-Mercedes Benz, develops upper-limb prosthetics and wearable robotic systems. Its GripX product is a myoelectric prosthetic hand designed for Indian clinical workflows. The company is also developing X1, a bionic hand, as part of its “Human Physical AI” vision.

Rymo Technologies Pvt. Ltd., founded in 2020, has developed a neuro-rehabilitation ecosystem combining robotics, VR, AI and electrical stimulation. Its product suite includes Mobi-L, Mend, Nudge, Aura XR and Pulse FES. The company said its products have been installed at 779 sites across 612 clinics and hospitals, including AIIMS, Apollo, Sakra and Manipal.

Translead Medtech Pvt. Ltd., a Bengaluru-based medical device company, has developed Stand at Eaze, an unpowered assistive chair that helps users sit and stand using a compliant hinge mechanism licensed exclusively from biomechanics research at the Indian Institute of Science. The device is CDSCO-registered as a Class A medical device, with clinical evaluation underway at partner hospitals.

Torchit, a social technology company, develops assistive technologies including the Saarthi Smart Mobility Aid, the Jyoti AI ecosystem, AI Vision Glasses and AI Reader, braille technologies and the Saksharta Inclusive Education Kit. The company works with government bodies, NGOs, hospitals and CSR partners and has impacted over 2 million lives across India and other emerging markets.

Visitors, media representatives, investors and potential industry partners can connect with BIRAC and the participating start-ups at the BIRAC pavilion at Bharat Mandapam through August 15, 2026, for information on BIRAC’s funding schemes and eligibility for start-ups and SMEs, bioincubation and infrastructure support, technology transfer, licensing and IP-related assistance, regulatory and market-access guidance, and partnership, collaboration and investment opportunities with the participating start-ups.

Leave A Reply

Your email address will not be published.